Predictable and precise template-free CRISPR editing of pathogenic variants

Following Cas9 cleavage, DNA repair without a donor template is generally considered stochastic, heterogeneous and impractical beyond gene disruption. Here, we show that template-free Cas9 editing is predictable and capable of precise repair to a predicted genotype, enabling correction of disease-as...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 563; no. 7733; pp. 646 - 651
Main Authors Shen, Max W., Arbab, Mandana, Hsu, Jonathan Y., Worstell, Daniel, Culbertson, Sannie J., Krabbe, Olga, Cassa, Christopher A., Liu, David R., Gifford, David K., Sherwood, Richard I.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.11.2018
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Following Cas9 cleavage, DNA repair without a donor template is generally considered stochastic, heterogeneous and impractical beyond gene disruption. Here, we show that template-free Cas9 editing is predictable and capable of precise repair to a predicted genotype, enabling correction of disease-associated mutations in humans. We constructed a library of 2,000 Cas9 guide RNAs paired with DNA target sites and trained inDelphi, a machine learning model that predicts genotypes and frequencies of 1- to 60-base-pair deletions and 1-base-pair insertions with high accuracy ( r  = 0.87) in five human and mouse cell lines. inDelphi predicts that 5–11% of Cas9 guide RNAs targeting the human genome are ‘precise-50’, yielding a single genotype comprising greater than or equal to 50% of all major editing products. We experimentally confirmed precise-50 insertions and deletions in 195 human disease-relevant alleles, including correction in primary patient-derived fibroblasts of pathogenic alleles to wild-type genotype for Hermansky–Pudlak syndrome and Menkes disease. This study establishes an approach for precise, template-free genome editing. The authors use a machine-learning algorithm to predict the spectrum of CRISPR–Cas9-nuclease-mediated DNA repair outcomes at human genomic target sites.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
M.W.S., J.Y.H., and D.K.G. contributed to the inDelphi model. M.W.S., M.A., C.A.C., D.R.L., D.K.G., and R.I.S. contributed to the editing libraries, assays, and applications. M.A. and R.I.S. contributed to the library experimental protocol and performed Lib-A and Lib-B experiments in mES, DNA repair-deficient mES, and U2OS cells. D.W., S.J.C., O.K., and R.I.S. performed 1bpDisInsLib experiments in mESCs and endogenous experiments in mES, HCT116, U2OS, and HEK293T cells. M.A. performed endogenous experiments in primary patient fibroblasts. M.W.S., J.Y.H., C.A.C., and D.K.G. contributed to algorithm development and computational analysis. M.W.S., M.A., D.R.L., D.K.G., and R.I.S. contributed to writing and editing the manuscript.
Author contributions
ISSN:0028-0836
1476-4687
1476-4687
DOI:10.1038/s41586-018-0686-x